An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect

Por um escritor misterioso

Last updated 10 março 2025

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe

Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology

The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology - Journal of Cardiac Failure

Biomedicines, Free Full-Text

An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study - The Lancet Oncology

Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study - The Lancet Regional Health – Western

A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM - eBioMedicine

An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect

Association Between Visceral Fat Area and Cancer Prognosis: A Population-Based Multicenter Prospective Study - The American Journal of Clinical Nutrition

Recomendado para você